Unknown

Dataset Information

0

Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding.


ABSTRACT: Mixed lineage leukemia (MLL) fusion proteins cause oncogenic transformation of hematopoietic cells by constitutive recruitment of elongation factors to HOX promoters, resulting in overexpression of target genes. The structural basis of transactivation by MLL fusion partners remains undetermined. We show that the ANC1 homology domain (AHD) of AF9, one of the most common MLL translocation partners, is intrinsically disordered and recruits multiple transcription factors through coupled folding and binding. We determined the structure of the AF9 AHD in complex with the elongation factor AF4 and show that aliphatic residues, which are conserved in each of the AF9 binding partners, form an integral part of the hydrophobic core of the complex. Nuclear magnetic resonance relaxation measurements show that AF9 retains significant dynamic behavior which may facilitate exchange between disordered partners. We propose that AF9 functions as a signaling hub that regulates transcription through dynamic recruitment of cofactors in normal hematopoiesis and in acute leukemia.

SUBMITTER: Leach BI 

PROVIDER: S-EPMC3545106 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

2020-01-01 | S-EPMC6947934 | BioStudies
2011-01-01 | S-EPMC3038424 | BioStudies
2015-01-01 | S-EPMC4426023 | BioStudies
2018-01-01 | S-EPMC5998191 | BioStudies
2020-01-01 | S-EPMC7497807 | BioStudies
1000-01-01 | S-EPMC3656630 | BioStudies
2012-01-01 | S-EPMC3382941 | BioStudies
2010-01-01 | S-EPMC2830208 | BioStudies
2011-01-01 | S-EPMC3179097 | BioStudies
1000-01-01 | S-EPMC3362364 | BioStudies